Nu-Med Plus (NUMD) EBT (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.45% |
| Sep 30, 2025 | -2.58% |
| Jun 30, 2025 | 41.48% |
| Mar 31, 2025 | -88.85% |
| Dec 31, 2024 | 43.49% |
| Sep 30, 2024 | -8.04% |
| Jun 30, 2024 | 20.80% |
| Mar 31, 2024 | 61.44% |
| Dec 31, 2023 | -244.97% |
| Sep 30, 2023 | 32.54% |
| Jun 30, 2023 | 13.77% |
| Mar 31, 2023 | -166.20% |
| Dec 31, 2022 | 173.40% |
| Sep 30, 2022 | 0.03% |
| Jun 30, 2022 | 2.65% |
| Mar 31, 2022 | 46.90% |
| Dec 31, 2021 | 5.09% |
| Sep 30, 2021 | 53.03% |
| Jun 30, 2021 | 29.36% |
| Mar 31, 2021 | 29.73% |
| Dec 31, 2020 | -11.87% |
| Sep 30, 2020 | 50.27% |
| Jun 30, 2020 | -495.10% |
| Mar 31, 2020 | 26.94% |
| Dec 31, 2019 | -39.39% |
| Sep 30, 2019 | 37.10% |
| Jun 30, 2019 | 42.90% |
| Mar 31, 2019 | -19.64% |
| Dec 31, 2018 | 32.26% |
| Sep 30, 2018 | -215.67% |
| Jun 30, 2018 | -19.12% |
| Mar 31, 2018 | -103.53% |
| Dec 31, 2017 | 3,043.52% |
| Sep 30, 2017 | -24.37% |
| Jun 30, 2017 | -61.88% |
| Mar 31, 2017 | -107.01% |
| Dec 31, 2016 | 236.00% |
| Sep 30, 2016 | -300.27% |
| Jun 30, 2016 | -186.73% |
| Mar 31, 2016 | -107.38% |
| Dec 31, 2015 | 372.37% |
| Sep 30, 2015 | 22.31% |
| Jun 30, 2015 | -235.80% |
| Mar 31, 2015 | 78.18% |
| Dec 31, 2014 | -123.85% |
| Sep 30, 2014 | -20.89% |
| Jun 30, 2014 | -34.63% |
| Sep 30, 2013 | -7.24% |
| Jun 30, 2013 | 60.27% |
| Mar 31, 2013 | 70.58% |